Central Nervous System Mechanisms of Obesity Hypertension
Central Nervous System Mechanisms of Obesity Hypertension
批准号:
8217289
负责人:
SEAN D STOCKER
金额:
$38.21万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-02-15 至 2014-01-31
关键词:
AcuteAngiotensin IIAnimal ModelArtsBlood PressureBody WeightBrainBrain StemChronicClinical ResearchDataDevelopmentDietEssential HypertensionFramingham Heart StudyGlutamate ReceptorGlutamatesGoalsHindlimbHormonesHumanHyperinsulinismHypertensionHypothalamic structureIndividualInsulinKidneyLaboratoriesLeptinLinkMediatingMelanocortin 4 ReceptorModelingNerveNeural PathwaysNeuraxisNeuronsNeurotransmitter ReceptorNeurotransmittersObesityPathogenesisPathway interactionsPhenotypePlasmaPlayPublishingRattusReceptor ActivationReceptor, Angiotensin, Type 1Renin-Angiotensin SystemRisk EstimateRodentRodent ModelRoleSignal TransductionSpinal CordStructure of nucleus infundibularis hypothalamiStudy modelsSympathetic Nervous SystemSynapsesTechniquesWomanWorkin vivomenneurochemistryneuromechanismneurotransmissionnovel therapeuticsparaventricular nucleusresearch studyresponse
中文摘要
描述(由申请人提供):来自心脏病研究的风险估计表明,约75%的男性原发性高血压和65%的女性原发性高血压主要归因于超重和肥胖。来自临床研究和动物模型的令人信服的证据表明,升高的交感神经流出到肾脏和后肢血管在肥胖引起的高血压的发病机制中起着关键作用。尽管体重或肥胖与交感神经系统激活之间存在重要关系,但对肥胖期间交感神经流出和动脉血压持续增加的神经通路和细胞机制知之甚少。我们实验室的长期目标是确定增加肥胖患者交感神经流出和血压的神经通路和细胞机制。高胰岛素血症和高瘦素血症被认为是介导肥胖患者交感神经流出和血压升高的两种脑传入信号。我们的工作假设是,饮食诱导的肥胖增加循环胰岛素和瘦素激活从弓状核到下丘脑室旁核的下行回路。随后下丘脑中的受体激活增加下丘脑室旁核中交感神经元的放电,以增强对脑干和脊髓的兴奋性驱动。这种增强的兴奋性驱动增加交感神经流出和动脉血压。在本申请中,我们将使用国家或最先进的电生理方法来确定支持肥胖引起的高血压的中枢机制。具体目标1将确定下丘脑室旁核内的细胞机制,高胰岛素血症和高瘦素血症增加交感神经流出。具体目标2将确定高胰岛素血症和高瘦素血症增加交感神经流出的延髓头端腹外侧的细胞机制。具体目标3将确定下丘脑室旁核和延髓头端腹外侧区内支持饮食诱导肥胖的啮齿动物模型中交感神经流出量和血压升高的机制。我们这个项目的基本原理是,确定神经通路和机制,介导的交感神经兴奋作用的胰岛素和瘦素,以及如何这些途径最终有助于肥胖引起的高血压将提供一个框架的发展新的治疗方法。项目叙述
最近的风险评估表明,高血压在很大程度上归因于超重或肥胖。
肥胖这项应用将确定大脑中联系肥胖和高血压的机制,
因此提供了一个框架,用于开发新的治疗性治疗肥胖的个人。
英文摘要
DESCRIPTION (provided by applicant): Risk estimates from the Framingham Heart Study indicate that ~75% of essential hypertension in men and 65% of essential hypertension in women is largely attributed to excess body weight and obesity. Convincing evidence from both clinical studies and animal models demonstrates that elevated sympathetic outflow to the kidney and hindlimb vasculature plays a pivotal role in the pathogenesis of obesity-induced hypertension. Despite the important relationship between body weight or adiposity and activation of the sympathetic nervous system, little is known regarding the neural pathways and cellular mechanisms that underlie the sustained increase in sympathetic outflow and arterial blood pressure during obesity. The long term goal of our laboratory is to identify the neural pathways and cellular mechanisms that increase sympathetic outflow and blood pressure in obesity. Two afferent signals to the brain postulated to mediate the elevated sympathetic outflow and blood pressure in obesity are hyperinsulinemia and hyperleptinemia. Our working hypothesis is that diet-induced obesity increases circulating insulin and leptin to activate a descending circuit from the arcuate nucleus to the hypothalamic paraventricular nucleus. Subsequent receptor activation in the hypothalamus increases the discharge of sympathetic neurons in the hypothalamic paraventricular nucleus to enhance excitatory drive to the brainstem and spinal cord. This enhanced excitatory drive increases sympathetic outflow and arterial blood pressure. In this application, we will use state-or-the-art electrophysiological approaches to identify the central mechanisms that support obesity-induced hypertension. Specific aim 1 will identify the cellular mechanisms within the hypothalamic paraventricular nucleus by which hyperinsulinemia and hyperleptinemia increase sympathetic outflow. Specific Aim 2 will identify the cellular mechanisms within the rostral ventrolateral medulla by which hyperinsulinemia and hyperleptinemia increase sympathetic outflow. Specific Aim 3 will identify the mechanisms within the hypothalamic paraventricular nucleus and rostral ventrolateral medulla that support the elevated sympathetic outflow and blood pressure in a rodent model of diet-induced obesity. Our rationale for this project is that identification of the neural pathways and mechanisms that mediate the sympathoexcitatory actions of insulin and leptin, and how these pathways ultimately contribute to obesity-induced hypertension will provide a framework for the development of novel therapeutic treatments. PROJECT NARRATIVE
Recent risk estimates indicate that high blood pressure is largely attributed to excess body weight or
obesity. This application will identify the mechanisms in the brain that link obesity and hypertension, and
therefore provide a framework for the development of novel therapeutic treatments in obese individuals.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1161/hypertensionaha.108.127803
发表时间:
2009-08
期刊:
Hypertension (Dallas, Tex. : 1979)
影响因子:
--
作者:
[Adams JM, Bardgett ME, Stocker SD]
通讯作者:
Stocker SD
DOI:
10.1161/hypertensionaha.109.146605
发表时间:
2010-02
期刊:
Hypertension (Dallas, Tex. : 1979)
影响因子:
--
作者:
[Bardgett ME, McCarthy JJ, Stocker SD]
通讯作者:
Stocker SD
Glutamate receptors in the hypothalamic paraventricular nucleus contribute to insulin-induced sympathoexcitation.
下丘脑室旁核中的谷氨酸受体有助于胰岛素诱导的交感兴奋。
DOI:
10.1152/jn.00764.2014
发表时间:
2015
期刊:
Journal of neurophysiology
影响因子:
2.5
作者:
[Stocker,SeanD, Gordon,KathrynW]
通讯作者:
Gordon,KathrynW
DOI:
10.1007/s11906-013-0385-9
发表时间:
2013-12
期刊:
CURRENT HYPERTENSION REPORTS
影响因子:
5.6
作者:
[Stocker, Sean D., Monahan, Kevin D., Browning, Kirsteen N.]
通讯作者:
Browning, Kirsteen N.
DOI:
10.1161/hypertensionaha.110.160671
发表时间:
2011-03
期刊:
Hypertension (Dallas, Tex. : 1979)
影响因子:
--
作者:
[Ward KR, Bardgett JF, Wolfgang L, Stocker SD]
通讯作者:
Stocker SD
共 7 条
Forebrain electroneutral transporters in salt-sensitive hypertension
-
批准号:10736529
-
项目类别:
-
资助金额:$72.04万
-
财政年份:2023
-
负责人:SEAN D STOCKER
-
依托单位:
Identification of mechano versus chemo-sensitive renal sensory neurons in hypertension
-
批准号:10392402
-
项目类别:
-
资助金额:$59.58万
-
财政年份:2020
-
负责人:SEAN D STOCKER
-
依托单位:
Identification of mechano versus chemo-sensitive renal sensory neurons in hypertension
-
批准号:10593129
-
项目类别:
-
资助金额:$59.81万
-
财政年份:2020
-
负责人:SEAN D STOCKER
-
依托单位:
Brain NaCl-sensing in salt-sensitive hypertension.
-
批准号:9974567
-
项目类别:
-
资助金额:$55.95万
-
财政年份:2019
-
负责人:SEAN D STOCKER
-
依托单位:
Brain NaCl-sensing in salt-sensitive hypertension.
-
批准号:10400857
-
项目类别:
-
资助金额:$55.95万
-
财政年份:2019
-
负责人:SEAN D STOCKER
-
依托单位:
Central Osmosensory Mechanisms in Salt-Sensitive Hypertension
-
批准号:8606887
-
项目类别:
-
资助金额:$36.68万
-
财政年份:2013
-
负责人:SEAN D STOCKER
-
依托单位:
Central Osmosensory Mechanisms in Salt-Sensitive Hypertension
-
批准号:9415263
-
项目类别:
-
资助金额:$30.59万
-
财政年份:2013
-
负责人:SEAN D STOCKER
-
依托单位:
Central Osmosensory Mechanisms in Salt-Sensitive Hypertension
-
批准号:8438620
-
项目类别:
-
资助金额:$37.45万
-
财政年份:2013
-
负责人:SEAN D STOCKER
-
依托单位:
Central Osmosensory Mechanisms in Salt-Sensitive Hypertension
-
批准号:8996700
-
项目类别:
-
资助金额:$6.79万
-
财政年份:2013
-
负责人:SEAN D STOCKER
-
依托单位:
Central Osmosensory Mechanisms in Salt-Sensitive Hypertension
-
批准号:8793209
-
项目类别:
-
资助金额:$36.84万
-
财政年份:2013
-
负责人:SEAN D STOCKER
-
依托单位:
Antihypertensive Effects of Tetanic Baraoreceptor Input Stimulation
-
批准号:8011973
-
项目类别:
-
资助金额:$19.39万
-
财政年份:2010
-
负责人:SEAN D STOCKER
-
依托单位:
Central Nervous System Mechanisms of Obesity Hypertension
-
批准号:8037116
-
项目类别:
-
资助金额:$38.6万
-
财政年份:2008
-
负责人:SEAN D STOCKER
-
依托单位:
Central Nervous System Mechanisms of Obesity Hypertension
-
批准号:7760628
-
项目类别:
-
资助金额:$38.61万
-
财政年份:2008
-
负责人:SEAN D STOCKER
-
依托单位:
Central Nervous System Mechanisms of Obesity Hypertension
-
批准号:7569403
-
项目类别:
-
资助金额:$36.21万
-
财政年份:2008
-
负责人:SEAN D STOCKER
-
依托单位:
Forebrain Neurohumoral Integration in Heart Failure
-
批准号:6876597
-
项目类别:
-
资助金额:$4.99万
-
财政年份:2003
-
负责人:SEAN D STOCKER
-
依托单位:
Forebrain Neurohumoral Integration in Heart Failure
-
批准号:6742430
-
项目类别:
-
资助金额:$4.73万
-
财政年份:2003
-
负责人:SEAN D STOCKER
-
依托单位:
Forebrain Neurohumoral Integration in Heart Failure
-
批准号:6648171
-
项目类别:
-
资助金额:$4.16万
-
财政年份:2003
-
负责人:SEAN D STOCKER
-
依托单位:
海外基金